Publications
5491 Results
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr 3588) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80405
Dietary fat intake in relation to overall and progression-free survival among people with advanced or metastatic colorectal cancer: data from CALGB 80405
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr 9582) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
- Year
- 2021
- Research Committee(s)
- Melanoma
- Study Number(s)
- CTSU/E1609
Granulomatous and sarcoid-like immune related adverse events (irAEs) in melanoma patients following CTLA4 blockade blockade adjuvant therapy: An analysis of 1670 high-risk patients
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr 3568) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80405
Influence of dietary insulin scores on survival in patients with metastatic colorectal cancer (mCRC): Findings from CALGB (Alliance) 80405
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr 8505) (American Society of Clinical Oncology Annual Meeting 2021, oral)
- Year
- 2021
- Research Committee(s)
- Lung
Phase III Comparison of High Dose Once-Daily (QD) Thoracic Radiotherapy (TRT) with Standard Twice-Daily (BID) TRT in limited stage small cell lung cancer (LSCLC): CALGB 30610 (Alliance) / RTOG 0538
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr 3591) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/N0147
Association of Adiponectin with Tumor Infiltrating Lymphocytes in Patients with Stage III Colon Cancer Treated in an Adjuvant Chemotherapy Trial (NCCTG N0147, Alliance)
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr TPS9585) (American Society of Clinical Oncology Annual Meeting 2021 (TIPS poster)
- Year
- 2021
- Research Committee(s)
- Melanoma
- Study Number(s)
- S1801
S1801: A randomized phase II trial of adjuvant versus neoadjuvant pembrolizumab (PEM) for melanoma
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr TPS3614) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/EA2176
A Randomized Phase III Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Naive Metastatic Anal Cancer Patients: A trial of the ECOG-ACRIN Cancer Research Group (EA2176)
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr 1518) (American Society of Clinical Oncology Annual Meeting 2021, poster discussion session)
- Year
- 2021
- Research Committee(s)
- Cancer Care Delivery
Baseline and short-term financial burden (FB) in colorectal cancer (CRC) treated with curative intent: early results of ECOG-ACRIN EAQ162CD
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr 12003) (American Society of Clinical Oncology Annual Meeting 2021, oral)
- Year
- 2021
- Research Committee(s)
- Breast
- Study Number(s)
- CTSU/E1Z11
Prospective Validation of Genetic Predictors of Aromatase Inhibitor-Associated Musculoskeletal Symptoms (AIMSS) in a Racially Diverse Cohort: Results from ECOG-ACRIN E1Z11
- Journal / Conference
- J Clin Oncol 39, 2021 (suppl 15; abstr TPS5098) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
- Year
- 2021
- Research Committee(s)
- Genitourinary